top of page
News & insights
AACPN press releases & statements
AACPN Statement on White House Support for Revising Federal Hemp Regulations
The White House has urged Congress to reconsider forthcoming federal hemp restrictions and instead pursue a comprehensive regulatory framework. AACPN welcomes the recommendation and outlines why responsible regulation, consumer protection, and evidence-based policymaking offer a stronger path forward than prohibition.
Press Release: NEW HEALTHCARE POLICY ORGANIZATION ANNOUNCES NATIONAL AGENDA TO EXPAND ACCESS TO EVIDENCE-BASED INTEGRATIVE AND ALTERNATIVE HEALTHCARE
The American Alternative Care Policy Network (AACPN) has announced a national policy agenda focused on expanding access to evidence-based integrative and alternative healthcare. Through its Alternative Care Access Campaign, Psychedelic Research Initiative, and Hemp Beverage Policy Initiative, AACPN seeks to advance healthcare access, scientific research, patient choice, and evidence-based policy for veterans, trauma survivors, first responders, and other underserved populatio
AACPN Applauds Connecticut Enactment of Public Act 26-108 Expanding Psychedelic-Assisted Therapy Research
AACPN applauds Connecticut’s enactment of Public Act 26-108, expanding the state’s psychedelic-assisted therapy pilot program and supporting continued clinical research involving MDMA and psilocybin therapies for veterans, first responders, trauma survivors, and individuals living with treatment-resistant mental health conditions.
AACPN in the news
Gordon Op-Ed: CT can be a national leader in evidence-based healthcare innovation
Originally published in the Hartford Courant, this op-ed examines Connecticut's Public Act 26-108 and its implications for psychedelic-assisted therapy, evidence-based healthcare innovation, and patient access.
AACPN's Adrian Bruneau Featured on The Decision Hour
AACPN Director of Political & Public Affairs Adrian Bruneau recently appeared on The Decision Hour to discuss veteran mental health, resilience, recovery, and the challenges of life after military service. Watch the full interview.
National news & research
Gordon Op-Ed: CT can be a national leader in evidence-based healthcare innovation
Originally published in the Hartford Courant, this op-ed examines Connecticut's Public Act 26-108 and its implications for psychedelic-assisted therapy, evidence-based healthcare innovation, and patient access.
HHS & VA Announce Bold, Comprehensive Partnership to Advance Rapid-Acting Mental Health Treatments for Veterans
The U.S. Department of Health and Human Services and the Department of Veterans Affairs have announced a landmark partnership to accelerate research and implementation of rapid-acting mental health treatments for veterans, including psychedelic-assisted therapies. Read the official federal announcement below.
Rand: Nearly 5 Million U.S. Veterans Have Used Psilocybin Mushrooms, LSD or MDMA; Veterans' Policy Preferences Differ by Psychedelic Substance
Nearly 5 Million U.S. Veterans Have Used Psilocybin Mushrooms, LSD or MDMA; Veterans' Policy Preferences Differ by Psychedelic Substance
Join our mailing list
bottom of page